熱門資訊> 正文
Voyager Therapeutics首席财务官辞职; Robin Swartz承担财务责任
2026-04-22 04:56
- Voyager Therapeutics (VYGR) announced on Tuesday in an SEC Form 8-K filing that its CFO, Nathan Jorgensen, has resigned, effective May 8, 2026, to take up a new opportunity.
- The Board has appointed Robin Swartz (current COO & CBO) as the new Principal Financial Officer and Treasurer, effective immediately upon transition, ensuring continuity in finance leadership.
- Adding to the leadership reshuffle, Amy Quinlan has been named Principal Accounting Officer, strengthening the company’s accounting oversight.
- Following the news, the stock closed ~2.60% lower at ~$4.12.
More on Voyager Therapeutics
- Voyager Therapeutics: 'Strong Buy' On Inflection Points For VY7523 In AD For 2026
- Voyager Therapeutics, Inc. (VYGR) Presents at Stifel 2026 Virtual CNS Forum Transcript
- Voyager Therapeutics, Inc. (VYGR) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript
- Seeking Alpha’s Quant Rating on Voyager Therapeutics
- Historical earnings data for Voyager Therapeutics
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。